AbbVie’s Power Play: How Skyrizi, Rinvoq, and a Surging Brain Business Are Crushing It (Even if Botox Isn’t)
AbbVie's Q3 2025 earnings are in. Skyrizi is on fire, neuroscience is booming, but Botox is a bust. Get the summary.
Sprouts’ Growth Hits a Wall: Why Strong Profits Can’t Hide a Worrying Slowdown
Sprouts' earnings show strong profit growth but a sales slowdown, as management blames a softening consumer and shows their strategy for 2026.
Earnings Rewind: Big Tech’s AI Bet & SoFi’s Fintech Shockwave
Looking at Big Tech AI Spending in the form of earnings from the big four tech players in this weeks Earnings Rewind.
